Search - tctmd.com

Displaying 801 - 819 of 819

Sort: Relevancy | Date

Presentation NY Valves 2024

Impact of Severity and Extent of Iliofemoral Atherosclerosis on Clinical Outcomes in Patients Undergoing TAVR

Presenter: Masaaki Nakase

June 05, 2024

Presentation NY Valves 2024

Progression of Mitral Regurgitation Severity After Transcatheter Tricuspid Valve Replacement

Presenter: Melissa Yen Yen Moey

June 05, 2024

Presentation NY Valves 2024

Experience-Based Lessons Learned from Real World T-TEER Cases

Presenter: Jörg Hausleiter

June 05, 2024

Presentation NY Valves 2024

The French Correction

Presenter: Gilles Daniel Dreyfus

June 05, 2024

Presentation NY Valves 2024

Case Presentation: A Healthy 55 Year-Old With Severe AS

Presenter: Michael I. Brener

June 05, 2024

Presentation NY Valves 2024

Paradoxical Low-Flow, Low-Gradient AS: Diagnosis and Management based on Multi-Modality Imaging

Presenter: Marie-Annick Clavel

June 05, 2024

Presentation NY Valves 2024

LVOTO Provocation During Mitral-TEER for Dynamic LVOTO: Poking the Bear

Presenter: Matteo Sturla

June 05, 2024

Presentation NY Valves 2024

Defining Technical Success Post-M-TEER: MR Reduction and Hemodynamics

Presenter: Amar Krishnaswamy

June 05, 2024

Presentation NY Valves 2024

Early Feasibility Studies: How to Enable Innovation While Maintaining Safety

Presenter: Aaron V. Kaplan

June 05, 2024

Video

» On Record

On Record: How the FDA Approval of Asymptomatic TAVI Has Changed Practice

August 6, 2025

Video

» Interview

New Tricuspid Therapies: From Clinical Trial to Clinical Practice

June 26, 2024

Video

» Interview

Treatment of AS in Young Patients

June 24, 2024

Video

» Interview

Regulatory Science Workshops: EFS 2.0 and Long-term Follow-Up

June 24, 2024

Video

» Interview

Preemptive (Early) TAVI in Severe and Moderate AS Patients

June 24, 2024

Video

» Interview

Introducing Target AS

June 24, 2024

Video

» Interview

Has Modern-Era GDMT Changed the Need for Mitral TEER in Secondary MR?

June 24, 2024

Video

» Interview

Bioprosthetic Valve Durability: What Do We Know?

June 24, 2024

Video

» Interview

Bicuspid Aortic Valve Controversies: The Next Steps

June 24, 2024

Video

» Interview

Advances in the Management of AR

June 24, 2024

Advertisement

Impact of Severity and Extent of Iliofemoral Atherosclerosis on Clinical Outcomes in Patients Undergoing TAVR

Progression of Mitral Regurgitation Severity After Transcatheter Tricuspid Valve Replacement

Experience-Based Lessons Learned from Real World T-TEER Cases

The French Correction

Case Presentation: A Healthy 55 Year-Old With Severe AS

Paradoxical Low-Flow, Low-Gradient AS: Diagnosis and Management based on Multi-Modality Imaging

LVOTO Provocation During Mitral-TEER for Dynamic LVOTO: Poking the Bear

Defining Technical Success Post-M-TEER: MR Reduction and Hemodynamics

Early Feasibility Studies: How to Enable Innovation While Maintaining Safety

On Record: How the FDA Approval of Asymptomatic TAVI Has Changed Practice

New Tricuspid Therapies: From Clinical Trial to Clinical Practice

Treatment of AS in Young Patients

Regulatory Science Workshops: EFS 2.0 and Long-term Follow-Up

Preemptive (Early) TAVI in Severe and Moderate AS Patients

Introducing Target AS

Has Modern-Era GDMT Changed the Need for Mitral TEER in Secondary MR?

Bioprosthetic Valve Durability: What Do We Know?

Bicuspid Aortic Valve Controversies: The Next Steps

Advances in the Management of AR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content